BMC MUSCULOSKELETAL DISORDERS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2164221, encodeId=60be21642210e, content=偏重的研究方向：脊柱 经验分享：23.9.11投稿，23.9.25过格式审查，十月初邀请到编辑处理，具体哪一天忘记了，然后送审以后处理速度还是很快，三位审稿人接受邀请，23.10.20第一位审稿人意见反馈，继续等待，希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/STQuHjjJKMYl69lTpXIUI5u3woQuKskqLpsia8jC0M8lfDTTISjic4ekEeDKYQ6B3iaedCtqiaQicAn2lKENsicHAsIQ/132, createdBy=a36c2405777, createdName=ssssdsfwaefwa, createdTime=Sun Oct 22 17:24:52 CST 2023, time=2023-10-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2172622, encodeId=62bf21e262257, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;骨科 经验分享：年中旬投了篇单细胞的生信，补实验后顺利接受，推荐给同学，上个月投了篇孟德尔，秒拒，我师兄的生信投这里也拒了，建议数据挖掘类的文章慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bad6163337, createdName=ms2000001312611838, createdTime=Sun Dec 03 09:29:36 CST 2023, time=2023-12-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2166338, encodeId=8a0d216633800, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投稿到接收差不多两个月，生信+实验验证，返修补了一些实验 Submission is in publishing and rights 30 Oct 2023 Submission accepted 30 Oct 2023 Submission under peer review 13 Oct 2023 Submission passed technical check 13 Oct 2023 Amendment received 13 Oct 2023 Revision received 11 Oct 2023 Submission under peer review 14 Sep 2023 Technical check Submission status Date Submission passed technical check 14 Sep 2023 Amendment received 14 Sep 2023 Submission is under technical check 23 Aug 2023 Submission received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/7e6dda2a286d404d897e281e83f93dee/0c32f4acbf6d461481aa19e7dc94d95f.png, createdBy=b4952354890, createdName=Adamt, createdTime=Thu Nov 02 18:20:20 CST 2023, time=2023-11-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2157142, encodeId=887d215e1427e, content=这个杂志技术审查那么久啊，一个月了，还没审查结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d1c5490951, createdName=万里无云, createdTime=Mon Sep 11 15:12:17 CST 2023, time=2023-09-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2099480, encodeId=81922099480b4, content=偏重的研究方向：骨科;骨性关节炎 经验分享：Editors invited一般持续多长时间，10月21号开始Editors invited到现在已经将近20天了，还没有动静，要不要催催，求助😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1688361305, createdName=ms3000000919382660, createdTime=Wed Nov 09 21:16:05 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131567, encodeId=d1d6213156e62, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：骨科 经验分享：投稿历时7个月，第4个月的时候还在邀请审稿人，写邮件问了一下，说找不到审稿人，第二天看到同时邀请40个审稿人，头一次见这么大的阵仗，最终有一个审稿人接受了审稿。第6个月的时候审稿意见回来了，编辑给了小修意见，认真修改后提交文章，最终拒了。拒稿的理由也够奇葩，说样本量和随访时间的问题。如果是这样，那就早点拒啊，真的是崩溃了。 Submission rejected 03May2023 Submission under peer review 07Apr2023 Submission passed technical check 07Apr2023 Revision received 07Apr2023 Submission under peer review 02 Nov 2022 Submission passed technical check 02Nov2022 Amendment received 02Nov2022 Submission is under technical check 270ct 2022 Submission received 270ct 2022 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230717/d63097b66c1440faac5ec06c017e0793/06610422a28d4ec6ae0d7bf160d09e30.jpg, createdBy=b4db1647753, createdName=ala, createdTime=Thu May 11 11:40:21 CST 2023, time=2023-05-11, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2162346, encodeId=c4232162346f0, content=上个月显示邀请30位审稿人，昨天显示邀请79位审稿人？？？？？啥意思？哪位大神指点一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca8e8585523, createdName=ms4000001388192116, createdTime=Thu Oct 12 13:01:03 CST 2023, time=2023-10-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2164004, encodeId=f7b92164004c8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：生物信息学 经验分享：Publishing and rights Submission status Date Publishing and rights complete 07 Sep 2023 Submission is in publishing and rights 07 Sep 2023 Peer review Submission status Date Submission accepted 05 Sep 2023 Submission under peer review 28 Aug 2023 Submission passed technical check 28 Aug 2023 Amendment received 24 Aug 2023 Amendment received 23 Aug 2023 Revision received 13 Aug 2023 Submission under peer review 25 Feb 2023 Technical check Submission status Date Submission passed technical check 25 Feb 2023 Amendment received 23 Feb 2023 Submission is under technical check 17 Feb 2023 Submission received Submission status Date Submission received 17 Feb 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bad6163337, createdName=ms2000001312611838, createdTime=Fri Oct 20 20:54:30 CST 2023, time=2023-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161997, encodeId=95c2216199efb, content=2023.04.17提交 2023.04.21外审 2023.08.30修稿 2023.09.13修回 2023.10.02二修 2023.10.10接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Tue Oct 10 16:57:31 CST 2023, time=2023-10-10, status=1, ipAttribution=塔斯马尼亚), GetPortalCommentsPageByObjectIdResponse(id=2145375, encodeId=d05521453e583, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：有限元;骨科 经验分享：我去年投稿的时候还感觉这个杂志社处理稿件还挺快的，今年突然就慢性下来了，初审都拖了1个星期，给的拒稿理由也很泛泛，感觉变天了啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOV8qWmN9XB26YdMI8wKzQLQO3ZOb9aicDDU9GDKyrZdE822FcswP6WCek3goEKXSY49Or6iaiaEZ2A/132, createdBy=01755164162, createdName=接骨中郎匠, createdTime=Thu Jun 29 08:30:19 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省)]

2023-10-22 ssssdsfwaefwa 来自四川省

偏重的研究方向：脊柱
经验分享：23.9.11投稿，23.9.25过格式审查，十月初邀请到编辑处理，具体哪一天忘记了，然后送审以后处理速度还是很快，三位审稿人接受邀请，23.10.20第一位审稿人意见反馈，继续等待，希望有个好结果

9 18

展开18条回复

[GetPortalCommentsPageByObjectIdResponse(id=2164221, encodeId=60be21642210e, content=偏重的研究方向：脊柱 经验分享：23.9.11投稿，23.9.25过格式审查，十月初邀请到编辑处理，具体哪一天忘记了，然后送审以后处理速度还是很快，三位审稿人接受邀请，23.10.20第一位审稿人意见反馈，继续等待，希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/STQuHjjJKMYl69lTpXIUI5u3woQuKskqLpsia8jC0M8lfDTTISjic4ekEeDKYQ6B3iaedCtqiaQicAn2lKENsicHAsIQ/132, createdBy=a36c2405777, createdName=ssssdsfwaefwa, createdTime=Sun Oct 22 17:24:52 CST 2023, time=2023-10-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2172622, encodeId=62bf21e262257, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;骨科 经验分享：年中旬投了篇单细胞的生信，补实验后顺利接受，推荐给同学，上个月投了篇孟德尔，秒拒，我师兄的生信投这里也拒了，建议数据挖掘类的文章慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bad6163337, createdName=ms2000001312611838, createdTime=Sun Dec 03 09:29:36 CST 2023, time=2023-12-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2166338, encodeId=8a0d216633800, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投稿到接收差不多两个月，生信+实验验证，返修补了一些实验 Submission is in publishing and rights 30 Oct 2023 Submission accepted 30 Oct 2023 Submission under peer review 13 Oct 2023 Submission passed technical check 13 Oct 2023 Amendment received 13 Oct 2023 Revision received 11 Oct 2023 Submission under peer review 14 Sep 2023 Technical check Submission status Date Submission passed technical check 14 Sep 2023 Amendment received 14 Sep 2023 Submission is under technical check 23 Aug 2023 Submission received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/7e6dda2a286d404d897e281e83f93dee/0c32f4acbf6d461481aa19e7dc94d95f.png, createdBy=b4952354890, createdName=Adamt, createdTime=Thu Nov 02 18:20:20 CST 2023, time=2023-11-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2157142, encodeId=887d215e1427e, content=这个杂志技术审查那么久啊，一个月了，还没审查结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d1c5490951, createdName=万里无云, createdTime=Mon Sep 11 15:12:17 CST 2023, time=2023-09-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2099480, encodeId=81922099480b4, content=偏重的研究方向：骨科;骨性关节炎 经验分享：Editors invited一般持续多长时间，10月21号开始Editors invited到现在已经将近20天了，还没有动静，要不要催催，求助😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1688361305, createdName=ms3000000919382660, createdTime=Wed Nov 09 21:16:05 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131567, encodeId=d1d6213156e62, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：骨科 经验分享：投稿历时7个月，第4个月的时候还在邀请审稿人，写邮件问了一下，说找不到审稿人，第二天看到同时邀请40个审稿人，头一次见这么大的阵仗，最终有一个审稿人接受了审稿。第6个月的时候审稿意见回来了，编辑给了小修意见，认真修改后提交文章，最终拒了。拒稿的理由也够奇葩，说样本量和随访时间的问题。如果是这样，那就早点拒啊，真的是崩溃了。 Submission rejected 03May2023 Submission under peer review 07Apr2023 Submission passed technical check 07Apr2023 Revision received 07Apr2023 Submission under peer review 02 Nov 2022 Submission passed technical check 02Nov2022 Amendment received 02Nov2022 Submission is under technical check 270ct 2022 Submission received 270ct 2022 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230717/d63097b66c1440faac5ec06c017e0793/06610422a28d4ec6ae0d7bf160d09e30.jpg, createdBy=b4db1647753, createdName=ala, createdTime=Thu May 11 11:40:21 CST 2023, time=2023-05-11, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2162346, encodeId=c4232162346f0, content=上个月显示邀请30位审稿人，昨天显示邀请79位审稿人？？？？？啥意思？哪位大神指点一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca8e8585523, createdName=ms4000001388192116, createdTime=Thu Oct 12 13:01:03 CST 2023, time=2023-10-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2164004, encodeId=f7b92164004c8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：生物信息学 经验分享：Publishing and rights Submission status Date Publishing and rights complete 07 Sep 2023 Submission is in publishing and rights 07 Sep 2023 Peer review Submission status Date Submission accepted 05 Sep 2023 Submission under peer review 28 Aug 2023 Submission passed technical check 28 Aug 2023 Amendment received 24 Aug 2023 Amendment received 23 Aug 2023 Revision received 13 Aug 2023 Submission under peer review 25 Feb 2023 Technical check Submission status Date Submission passed technical check 25 Feb 2023 Amendment received 23 Feb 2023 Submission is under technical check 17 Feb 2023 Submission received Submission status Date Submission received 17 Feb 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bad6163337, createdName=ms2000001312611838, createdTime=Fri Oct 20 20:54:30 CST 2023, time=2023-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161997, encodeId=95c2216199efb, content=2023.04.17提交 2023.04.21外审 2023.08.30修稿 2023.09.13修回 2023.10.02二修 2023.10.10接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Tue Oct 10 16:57:31 CST 2023, time=2023-10-10, status=1, ipAttribution=塔斯马尼亚), GetPortalCommentsPageByObjectIdResponse(id=2145375, encodeId=d05521453e583, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：有限元;骨科 经验分享：我去年投稿的时候还感觉这个杂志社处理稿件还挺快的，今年突然就慢性下来了，初审都拖了1个星期，给的拒稿理由也很泛泛，感觉变天了啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOV8qWmN9XB26YdMI8wKzQLQO3ZOb9aicDDU9GDKyrZdE822FcswP6WCek3goEKXSY49Or6iaiaEZ2A/132, createdBy=01755164162, createdName=接骨中郎匠, createdTime=Thu Jun 29 08:30:19 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省)]

2023-12-03 ms2000001312611838 来自山西省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：脊柱;骨科
经验分享：年中旬投了篇单细胞的生信，补实验后顺利接受，推荐给同学，上个月投了篇孟德尔，秒拒，我师兄的生信投这里也拒了，建议数据挖掘类的文章慎投

3 0

[GetPortalCommentsPageByObjectIdResponse(id=2164221, encodeId=60be21642210e, content=偏重的研究方向：脊柱 经验分享：23.9.11投稿，23.9.25过格式审查，十月初邀请到编辑处理，具体哪一天忘记了，然后送审以后处理速度还是很快，三位审稿人接受邀请，23.10.20第一位审稿人意见反馈，继续等待，希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/STQuHjjJKMYl69lTpXIUI5u3woQuKskqLpsia8jC0M8lfDTTISjic4ekEeDKYQ6B3iaedCtqiaQicAn2lKENsicHAsIQ/132, createdBy=a36c2405777, createdName=ssssdsfwaefwa, createdTime=Sun Oct 22 17:24:52 CST 2023, time=2023-10-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2172622, encodeId=62bf21e262257, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;骨科 经验分享：年中旬投了篇单细胞的生信，补实验后顺利接受，推荐给同学，上个月投了篇孟德尔，秒拒，我师兄的生信投这里也拒了，建议数据挖掘类的文章慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bad6163337, createdName=ms2000001312611838, createdTime=Sun Dec 03 09:29:36 CST 2023, time=2023-12-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2166338, encodeId=8a0d216633800, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投稿到接收差不多两个月，生信+实验验证，返修补了一些实验 Submission is in publishing and rights 30 Oct 2023 Submission accepted 30 Oct 2023 Submission under peer review 13 Oct 2023 Submission passed technical check 13 Oct 2023 Amendment received 13 Oct 2023 Revision received 11 Oct 2023 Submission under peer review 14 Sep 2023 Technical check Submission status Date Submission passed technical check 14 Sep 2023 Amendment received 14 Sep 2023 Submission is under technical check 23 Aug 2023 Submission received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/7e6dda2a286d404d897e281e83f93dee/0c32f4acbf6d461481aa19e7dc94d95f.png, createdBy=b4952354890, createdName=Adamt, createdTime=Thu Nov 02 18:20:20 CST 2023, time=2023-11-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2157142, encodeId=887d215e1427e, content=这个杂志技术审查那么久啊，一个月了，还没审查结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d1c5490951, createdName=万里无云, createdTime=Mon Sep 11 15:12:17 CST 2023, time=2023-09-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2099480, encodeId=81922099480b4, content=偏重的研究方向：骨科;骨性关节炎 经验分享：Editors invited一般持续多长时间，10月21号开始Editors invited到现在已经将近20天了，还没有动静，要不要催催，求助😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1688361305, createdName=ms3000000919382660, createdTime=Wed Nov 09 21:16:05 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131567, encodeId=d1d6213156e62, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：骨科 经验分享：投稿历时7个月，第4个月的时候还在邀请审稿人，写邮件问了一下，说找不到审稿人，第二天看到同时邀请40个审稿人，头一次见这么大的阵仗，最终有一个审稿人接受了审稿。第6个月的时候审稿意见回来了，编辑给了小修意见，认真修改后提交文章，最终拒了。拒稿的理由也够奇葩，说样本量和随访时间的问题。如果是这样，那就早点拒啊，真的是崩溃了。 Submission rejected 03May2023 Submission under peer review 07Apr2023 Submission passed technical check 07Apr2023 Revision received 07Apr2023 Submission under peer review 02 Nov 2022 Submission passed technical check 02Nov2022 Amendment received 02Nov2022 Submission is under technical check 270ct 2022 Submission received 270ct 2022 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230717/d63097b66c1440faac5ec06c017e0793/06610422a28d4ec6ae0d7bf160d09e30.jpg, createdBy=b4db1647753, createdName=ala, createdTime=Thu May 11 11:40:21 CST 2023, time=2023-05-11, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2162346, encodeId=c4232162346f0, content=上个月显示邀请30位审稿人，昨天显示邀请79位审稿人？？？？？啥意思？哪位大神指点一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca8e8585523, createdName=ms4000001388192116, createdTime=Thu Oct 12 13:01:03 CST 2023, time=2023-10-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2164004, encodeId=f7b92164004c8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：生物信息学 经验分享：Publishing and rights Submission status Date Publishing and rights complete 07 Sep 2023 Submission is in publishing and rights 07 Sep 2023 Peer review Submission status Date Submission accepted 05 Sep 2023 Submission under peer review 28 Aug 2023 Submission passed technical check 28 Aug 2023 Amendment received 24 Aug 2023 Amendment received 23 Aug 2023 Revision received 13 Aug 2023 Submission under peer review 25 Feb 2023 Technical check Submission status Date Submission passed technical check 25 Feb 2023 Amendment received 23 Feb 2023 Submission is under technical check 17 Feb 2023 Submission received Submission status Date Submission received 17 Feb 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bad6163337, createdName=ms2000001312611838, createdTime=Fri Oct 20 20:54:30 CST 2023, time=2023-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161997, encodeId=95c2216199efb, content=2023.04.17提交 2023.04.21外审 2023.08.30修稿 2023.09.13修回 2023.10.02二修 2023.10.10接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Tue Oct 10 16:57:31 CST 2023, time=2023-10-10, status=1, ipAttribution=塔斯马尼亚), GetPortalCommentsPageByObjectIdResponse(id=2145375, encodeId=d05521453e583, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：有限元;骨科 经验分享：我去年投稿的时候还感觉这个杂志社处理稿件还挺快的，今年突然就慢性下来了，初审都拖了1个星期，给的拒稿理由也很泛泛，感觉变天了啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOV8qWmN9XB26YdMI8wKzQLQO3ZOb9aicDDU9GDKyrZdE822FcswP6WCek3goEKXSY49Or6iaiaEZ2A/132, createdBy=01755164162, createdName=接骨中郎匠, createdTime=Thu Jun 29 08:30:19 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省)]

2023-11-02 Adamt 来自陕西省

审稿速度:2.0 | 投稿命中率:95.0
经验分享：投稿到接收差不多两个月，生信+实验验证，返修补了一些实验
Submission is in publishing and rights
30 Oct 2023
Submission accepted
30 Oct 2023
Submission under peer review
13 Oct 2023
Submission passed technical check
13 Oct 2023
Amendment received
13 Oct 2023
Revision received
11 Oct 2023
Submission under peer review
14 Sep 2023
Technical check
Submission status Date
Submission passed technical check
14 Sep 2023
Amendment received
14 Sep 2023
Submission is under technical check
23 Aug 2023
Submission received

13 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2164221, encodeId=60be21642210e, content=偏重的研究方向：脊柱 经验分享：23.9.11投稿，23.9.25过格式审查，十月初邀请到编辑处理，具体哪一天忘记了，然后送审以后处理速度还是很快，三位审稿人接受邀请，23.10.20第一位审稿人意见反馈，继续等待，希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/STQuHjjJKMYl69lTpXIUI5u3woQuKskqLpsia8jC0M8lfDTTISjic4ekEeDKYQ6B3iaedCtqiaQicAn2lKENsicHAsIQ/132, createdBy=a36c2405777, createdName=ssssdsfwaefwa, createdTime=Sun Oct 22 17:24:52 CST 2023, time=2023-10-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2172622, encodeId=62bf21e262257, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;骨科 经验分享：年中旬投了篇单细胞的生信，补实验后顺利接受，推荐给同学，上个月投了篇孟德尔，秒拒，我师兄的生信投这里也拒了，建议数据挖掘类的文章慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bad6163337, createdName=ms2000001312611838, createdTime=Sun Dec 03 09:29:36 CST 2023, time=2023-12-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2166338, encodeId=8a0d216633800, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投稿到接收差不多两个月，生信+实验验证，返修补了一些实验 Submission is in publishing and rights 30 Oct 2023 Submission accepted 30 Oct 2023 Submission under peer review 13 Oct 2023 Submission passed technical check 13 Oct 2023 Amendment received 13 Oct 2023 Revision received 11 Oct 2023 Submission under peer review 14 Sep 2023 Technical check Submission status Date Submission passed technical check 14 Sep 2023 Amendment received 14 Sep 2023 Submission is under technical check 23 Aug 2023 Submission received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/7e6dda2a286d404d897e281e83f93dee/0c32f4acbf6d461481aa19e7dc94d95f.png, createdBy=b4952354890, createdName=Adamt, createdTime=Thu Nov 02 18:20:20 CST 2023, time=2023-11-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2157142, encodeId=887d215e1427e, content=这个杂志技术审查那么久啊，一个月了，还没审查结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d1c5490951, createdName=万里无云, createdTime=Mon Sep 11 15:12:17 CST 2023, time=2023-09-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2099480, encodeId=81922099480b4, content=偏重的研究方向：骨科;骨性关节炎 经验分享：Editors invited一般持续多长时间，10月21号开始Editors invited到现在已经将近20天了，还没有动静，要不要催催，求助😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1688361305, createdName=ms3000000919382660, createdTime=Wed Nov 09 21:16:05 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131567, encodeId=d1d6213156e62, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：骨科 经验分享：投稿历时7个月，第4个月的时候还在邀请审稿人，写邮件问了一下，说找不到审稿人，第二天看到同时邀请40个审稿人，头一次见这么大的阵仗，最终有一个审稿人接受了审稿。第6个月的时候审稿意见回来了，编辑给了小修意见，认真修改后提交文章，最终拒了。拒稿的理由也够奇葩，说样本量和随访时间的问题。如果是这样，那就早点拒啊，真的是崩溃了。 Submission rejected 03May2023 Submission under peer review 07Apr2023 Submission passed technical check 07Apr2023 Revision received 07Apr2023 Submission under peer review 02 Nov 2022 Submission passed technical check 02Nov2022 Amendment received 02Nov2022 Submission is under technical check 270ct 2022 Submission received 270ct 2022 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230717/d63097b66c1440faac5ec06c017e0793/06610422a28d4ec6ae0d7bf160d09e30.jpg, createdBy=b4db1647753, createdName=ala, createdTime=Thu May 11 11:40:21 CST 2023, time=2023-05-11, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2162346, encodeId=c4232162346f0, content=上个月显示邀请30位审稿人，昨天显示邀请79位审稿人？？？？？啥意思？哪位大神指点一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca8e8585523, createdName=ms4000001388192116, createdTime=Thu Oct 12 13:01:03 CST 2023, time=2023-10-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2164004, encodeId=f7b92164004c8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：生物信息学 经验分享：Publishing and rights Submission status Date Publishing and rights complete 07 Sep 2023 Submission is in publishing and rights 07 Sep 2023 Peer review Submission status Date Submission accepted 05 Sep 2023 Submission under peer review 28 Aug 2023 Submission passed technical check 28 Aug 2023 Amendment received 24 Aug 2023 Amendment received 23 Aug 2023 Revision received 13 Aug 2023 Submission under peer review 25 Feb 2023 Technical check Submission status Date Submission passed technical check 25 Feb 2023 Amendment received 23 Feb 2023 Submission is under technical check 17 Feb 2023 Submission received Submission status Date Submission received 17 Feb 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bad6163337, createdName=ms2000001312611838, createdTime=Fri Oct 20 20:54:30 CST 2023, time=2023-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161997, encodeId=95c2216199efb, content=2023.04.17提交 2023.04.21外审 2023.08.30修稿 2023.09.13修回 2023.10.02二修 2023.10.10接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Tue Oct 10 16:57:31 CST 2023, time=2023-10-10, status=1, ipAttribution=塔斯马尼亚), GetPortalCommentsPageByObjectIdResponse(id=2145375, encodeId=d05521453e583, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：有限元;骨科 经验分享：我去年投稿的时候还感觉这个杂志社处理稿件还挺快的，今年突然就慢性下来了，初审都拖了1个星期，给的拒稿理由也很泛泛，感觉变天了啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOV8qWmN9XB26YdMI8wKzQLQO3ZOb9aicDDU9GDKyrZdE822FcswP6WCek3goEKXSY49Or6iaiaEZ2A/132, createdBy=01755164162, createdName=接骨中郎匠, createdTime=Thu Jun 29 08:30:19 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省)]

2023-09-11 万里无云来自河北省

这个杂志技术审查那么久啊，一个月了，还没审查结束

41 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2164221, encodeId=60be21642210e, content=偏重的研究方向：脊柱 经验分享：23.9.11投稿，23.9.25过格式审查，十月初邀请到编辑处理，具体哪一天忘记了，然后送审以后处理速度还是很快，三位审稿人接受邀请，23.10.20第一位审稿人意见反馈，继续等待，希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/STQuHjjJKMYl69lTpXIUI5u3woQuKskqLpsia8jC0M8lfDTTISjic4ekEeDKYQ6B3iaedCtqiaQicAn2lKENsicHAsIQ/132, createdBy=a36c2405777, createdName=ssssdsfwaefwa, createdTime=Sun Oct 22 17:24:52 CST 2023, time=2023-10-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2172622, encodeId=62bf21e262257, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;骨科 经验分享：年中旬投了篇单细胞的生信，补实验后顺利接受，推荐给同学，上个月投了篇孟德尔，秒拒，我师兄的生信投这里也拒了，建议数据挖掘类的文章慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bad6163337, createdName=ms2000001312611838, createdTime=Sun Dec 03 09:29:36 CST 2023, time=2023-12-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2166338, encodeId=8a0d216633800, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投稿到接收差不多两个月，生信+实验验证，返修补了一些实验 Submission is in publishing and rights 30 Oct 2023 Submission accepted 30 Oct 2023 Submission under peer review 13 Oct 2023 Submission passed technical check 13 Oct 2023 Amendment received 13 Oct 2023 Revision received 11 Oct 2023 Submission under peer review 14 Sep 2023 Technical check Submission status Date Submission passed technical check 14 Sep 2023 Amendment received 14 Sep 2023 Submission is under technical check 23 Aug 2023 Submission received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/7e6dda2a286d404d897e281e83f93dee/0c32f4acbf6d461481aa19e7dc94d95f.png, createdBy=b4952354890, createdName=Adamt, createdTime=Thu Nov 02 18:20:20 CST 2023, time=2023-11-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2157142, encodeId=887d215e1427e, content=这个杂志技术审查那么久啊，一个月了，还没审查结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d1c5490951, createdName=万里无云, createdTime=Mon Sep 11 15:12:17 CST 2023, time=2023-09-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2099480, encodeId=81922099480b4, content=偏重的研究方向：骨科;骨性关节炎 经验分享：Editors invited一般持续多长时间，10月21号开始Editors invited到现在已经将近20天了，还没有动静，要不要催催，求助😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1688361305, createdName=ms3000000919382660, createdTime=Wed Nov 09 21:16:05 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131567, encodeId=d1d6213156e62, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：骨科 经验分享：投稿历时7个月，第4个月的时候还在邀请审稿人，写邮件问了一下，说找不到审稿人，第二天看到同时邀请40个审稿人，头一次见这么大的阵仗，最终有一个审稿人接受了审稿。第6个月的时候审稿意见回来了，编辑给了小修意见，认真修改后提交文章，最终拒了。拒稿的理由也够奇葩，说样本量和随访时间的问题。如果是这样，那就早点拒啊，真的是崩溃了。 Submission rejected 03May2023 Submission under peer review 07Apr2023 Submission passed technical check 07Apr2023 Revision received 07Apr2023 Submission under peer review 02 Nov 2022 Submission passed technical check 02Nov2022 Amendment received 02Nov2022 Submission is under technical check 270ct 2022 Submission received 270ct 2022 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230717/d63097b66c1440faac5ec06c017e0793/06610422a28d4ec6ae0d7bf160d09e30.jpg, createdBy=b4db1647753, createdName=ala, createdTime=Thu May 11 11:40:21 CST 2023, time=2023-05-11, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2162346, encodeId=c4232162346f0, content=上个月显示邀请30位审稿人，昨天显示邀请79位审稿人？？？？？啥意思？哪位大神指点一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca8e8585523, createdName=ms4000001388192116, createdTime=Thu Oct 12 13:01:03 CST 2023, time=2023-10-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2164004, encodeId=f7b92164004c8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：生物信息学 经验分享：Publishing and rights Submission status Date Publishing and rights complete 07 Sep 2023 Submission is in publishing and rights 07 Sep 2023 Peer review Submission status Date Submission accepted 05 Sep 2023 Submission under peer review 28 Aug 2023 Submission passed technical check 28 Aug 2023 Amendment received 24 Aug 2023 Amendment received 23 Aug 2023 Revision received 13 Aug 2023 Submission under peer review 25 Feb 2023 Technical check Submission status Date Submission passed technical check 25 Feb 2023 Amendment received 23 Feb 2023 Submission is under technical check 17 Feb 2023 Submission received Submission status Date Submission received 17 Feb 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bad6163337, createdName=ms2000001312611838, createdTime=Fri Oct 20 20:54:30 CST 2023, time=2023-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161997, encodeId=95c2216199efb, content=2023.04.17提交 2023.04.21外审 2023.08.30修稿 2023.09.13修回 2023.10.02二修 2023.10.10接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Tue Oct 10 16:57:31 CST 2023, time=2023-10-10, status=1, ipAttribution=塔斯马尼亚), GetPortalCommentsPageByObjectIdResponse(id=2145375, encodeId=d05521453e583, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：有限元;骨科 经验分享：我去年投稿的时候还感觉这个杂志社处理稿件还挺快的，今年突然就慢性下来了，初审都拖了1个星期，给的拒稿理由也很泛泛，感觉变天了啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOV8qWmN9XB26YdMI8wKzQLQO3ZOb9aicDDU9GDKyrZdE822FcswP6WCek3goEKXSY49Or6iaiaEZ2A/132, createdBy=01755164162, createdName=接骨中郎匠, createdTime=Thu Jun 29 08:30:19 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省)]

2022-11-09 ms3000000919382660

偏重的研究方向：骨科;骨性关节炎
经验分享：Editors invited一般持续多长时间，10月21号开始Editors invited到现在已经将近20天了，还没有动静，要不要催催，求助😭😭

124 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2164221, encodeId=60be21642210e, content=偏重的研究方向：脊柱 经验分享：23.9.11投稿，23.9.25过格式审查，十月初邀请到编辑处理，具体哪一天忘记了，然后送审以后处理速度还是很快，三位审稿人接受邀请，23.10.20第一位审稿人意见反馈，继续等待，希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/STQuHjjJKMYl69lTpXIUI5u3woQuKskqLpsia8jC0M8lfDTTISjic4ekEeDKYQ6B3iaedCtqiaQicAn2lKENsicHAsIQ/132, createdBy=a36c2405777, createdName=ssssdsfwaefwa, createdTime=Sun Oct 22 17:24:52 CST 2023, time=2023-10-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2172622, encodeId=62bf21e262257, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;骨科 经验分享：年中旬投了篇单细胞的生信，补实验后顺利接受，推荐给同学，上个月投了篇孟德尔，秒拒，我师兄的生信投这里也拒了，建议数据挖掘类的文章慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bad6163337, createdName=ms2000001312611838, createdTime=Sun Dec 03 09:29:36 CST 2023, time=2023-12-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2166338, encodeId=8a0d216633800, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投稿到接收差不多两个月，生信+实验验证，返修补了一些实验 Submission is in publishing and rights 30 Oct 2023 Submission accepted 30 Oct 2023 Submission under peer review 13 Oct 2023 Submission passed technical check 13 Oct 2023 Amendment received 13 Oct 2023 Revision received 11 Oct 2023 Submission under peer review 14 Sep 2023 Technical check Submission status Date Submission passed technical check 14 Sep 2023 Amendment received 14 Sep 2023 Submission is under technical check 23 Aug 2023 Submission received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/7e6dda2a286d404d897e281e83f93dee/0c32f4acbf6d461481aa19e7dc94d95f.png, createdBy=b4952354890, createdName=Adamt, createdTime=Thu Nov 02 18:20:20 CST 2023, time=2023-11-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2157142, encodeId=887d215e1427e, content=这个杂志技术审查那么久啊，一个月了，还没审查结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d1c5490951, createdName=万里无云, createdTime=Mon Sep 11 15:12:17 CST 2023, time=2023-09-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2099480, encodeId=81922099480b4, content=偏重的研究方向：骨科;骨性关节炎 经验分享：Editors invited一般持续多长时间，10月21号开始Editors invited到现在已经将近20天了，还没有动静，要不要催催，求助😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1688361305, createdName=ms3000000919382660, createdTime=Wed Nov 09 21:16:05 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131567, encodeId=d1d6213156e62, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：骨科 经验分享：投稿历时7个月，第4个月的时候还在邀请审稿人，写邮件问了一下，说找不到审稿人，第二天看到同时邀请40个审稿人，头一次见这么大的阵仗，最终有一个审稿人接受了审稿。第6个月的时候审稿意见回来了，编辑给了小修意见，认真修改后提交文章，最终拒了。拒稿的理由也够奇葩，说样本量和随访时间的问题。如果是这样，那就早点拒啊，真的是崩溃了。 Submission rejected 03May2023 Submission under peer review 07Apr2023 Submission passed technical check 07Apr2023 Revision received 07Apr2023 Submission under peer review 02 Nov 2022 Submission passed technical check 02Nov2022 Amendment received 02Nov2022 Submission is under technical check 270ct 2022 Submission received 270ct 2022 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230717/d63097b66c1440faac5ec06c017e0793/06610422a28d4ec6ae0d7bf160d09e30.jpg, createdBy=b4db1647753, createdName=ala, createdTime=Thu May 11 11:40:21 CST 2023, time=2023-05-11, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2162346, encodeId=c4232162346f0, content=上个月显示邀请30位审稿人，昨天显示邀请79位审稿人？？？？？啥意思？哪位大神指点一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca8e8585523, createdName=ms4000001388192116, createdTime=Thu Oct 12 13:01:03 CST 2023, time=2023-10-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2164004, encodeId=f7b92164004c8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：生物信息学 经验分享：Publishing and rights Submission status Date Publishing and rights complete 07 Sep 2023 Submission is in publishing and rights 07 Sep 2023 Peer review Submission status Date Submission accepted 05 Sep 2023 Submission under peer review 28 Aug 2023 Submission passed technical check 28 Aug 2023 Amendment received 24 Aug 2023 Amendment received 23 Aug 2023 Revision received 13 Aug 2023 Submission under peer review 25 Feb 2023 Technical check Submission status Date Submission passed technical check 25 Feb 2023 Amendment received 23 Feb 2023 Submission is under technical check 17 Feb 2023 Submission received Submission status Date Submission received 17 Feb 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bad6163337, createdName=ms2000001312611838, createdTime=Fri Oct 20 20:54:30 CST 2023, time=2023-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161997, encodeId=95c2216199efb, content=2023.04.17提交 2023.04.21外审 2023.08.30修稿 2023.09.13修回 2023.10.02二修 2023.10.10接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Tue Oct 10 16:57:31 CST 2023, time=2023-10-10, status=1, ipAttribution=塔斯马尼亚), GetPortalCommentsPageByObjectIdResponse(id=2145375, encodeId=d05521453e583, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：有限元;骨科 经验分享：我去年投稿的时候还感觉这个杂志社处理稿件还挺快的，今年突然就慢性下来了，初审都拖了1个星期，给的拒稿理由也很泛泛，感觉变天了啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOV8qWmN9XB26YdMI8wKzQLQO3ZOb9aicDDU9GDKyrZdE822FcswP6WCek3goEKXSY49Or6iaiaEZ2A/132, createdBy=01755164162, createdName=接骨中郎匠, createdTime=Thu Jun 29 08:30:19 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省)]

2023-05-11 ala 来自陕西省

审稿速度:6.0 | 投稿命中率:5.0
偏重的研究方向：骨科
经验分享：投稿历时7个月，第4个月的时候还在邀请审稿人，写邮件问了一下，说找不到审稿人，第二天看到同时邀请40个审稿人，头一次见这么大的阵仗，最终有一个审稿人接受了审稿。第6个月的时候审稿意见回来了，编辑给了小修意见，认真修改后提交文章，最终拒了。拒稿的理由也够奇葩，说样本量和随访时间的问题。如果是这样，那就早点拒啊，真的是崩溃了。

Submission rejected 03May2023
Submission under peer review 07Apr2023
Submission passed technical check 07Apr2023
Revision received 07Apr2023
Submission under peer review 02 Nov 2022
Submission passed technical check 02Nov2022
Amendment received 02Nov2022
Submission is under technical check 270ct 2022
Submission received 270ct 2022

89 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2164221, encodeId=60be21642210e, content=偏重的研究方向：脊柱 经验分享：23.9.11投稿，23.9.25过格式审查，十月初邀请到编辑处理，具体哪一天忘记了，然后送审以后处理速度还是很快，三位审稿人接受邀请，23.10.20第一位审稿人意见反馈，继续等待，希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/STQuHjjJKMYl69lTpXIUI5u3woQuKskqLpsia8jC0M8lfDTTISjic4ekEeDKYQ6B3iaedCtqiaQicAn2lKENsicHAsIQ/132, createdBy=a36c2405777, createdName=ssssdsfwaefwa, createdTime=Sun Oct 22 17:24:52 CST 2023, time=2023-10-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2172622, encodeId=62bf21e262257, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;骨科 经验分享：年中旬投了篇单细胞的生信，补实验后顺利接受，推荐给同学，上个月投了篇孟德尔，秒拒，我师兄的生信投这里也拒了，建议数据挖掘类的文章慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bad6163337, createdName=ms2000001312611838, createdTime=Sun Dec 03 09:29:36 CST 2023, time=2023-12-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2166338, encodeId=8a0d216633800, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投稿到接收差不多两个月，生信+实验验证，返修补了一些实验 Submission is in publishing and rights 30 Oct 2023 Submission accepted 30 Oct 2023 Submission under peer review 13 Oct 2023 Submission passed technical check 13 Oct 2023 Amendment received 13 Oct 2023 Revision received 11 Oct 2023 Submission under peer review 14 Sep 2023 Technical check Submission status Date Submission passed technical check 14 Sep 2023 Amendment received 14 Sep 2023 Submission is under technical check 23 Aug 2023 Submission received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/7e6dda2a286d404d897e281e83f93dee/0c32f4acbf6d461481aa19e7dc94d95f.png, createdBy=b4952354890, createdName=Adamt, createdTime=Thu Nov 02 18:20:20 CST 2023, time=2023-11-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2157142, encodeId=887d215e1427e, content=这个杂志技术审查那么久啊，一个月了，还没审查结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d1c5490951, createdName=万里无云, createdTime=Mon Sep 11 15:12:17 CST 2023, time=2023-09-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2099480, encodeId=81922099480b4, content=偏重的研究方向：骨科;骨性关节炎 经验分享：Editors invited一般持续多长时间，10月21号开始Editors invited到现在已经将近20天了，还没有动静，要不要催催，求助😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1688361305, createdName=ms3000000919382660, createdTime=Wed Nov 09 21:16:05 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131567, encodeId=d1d6213156e62, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：骨科 经验分享：投稿历时7个月，第4个月的时候还在邀请审稿人，写邮件问了一下，说找不到审稿人，第二天看到同时邀请40个审稿人，头一次见这么大的阵仗，最终有一个审稿人接受了审稿。第6个月的时候审稿意见回来了，编辑给了小修意见，认真修改后提交文章，最终拒了。拒稿的理由也够奇葩，说样本量和随访时间的问题。如果是这样，那就早点拒啊，真的是崩溃了。 Submission rejected 03May2023 Submission under peer review 07Apr2023 Submission passed technical check 07Apr2023 Revision received 07Apr2023 Submission under peer review 02 Nov 2022 Submission passed technical check 02Nov2022 Amendment received 02Nov2022 Submission is under technical check 270ct 2022 Submission received 270ct 2022 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230717/d63097b66c1440faac5ec06c017e0793/06610422a28d4ec6ae0d7bf160d09e30.jpg, createdBy=b4db1647753, createdName=ala, createdTime=Thu May 11 11:40:21 CST 2023, time=2023-05-11, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2162346, encodeId=c4232162346f0, content=上个月显示邀请30位审稿人，昨天显示邀请79位审稿人？？？？？啥意思？哪位大神指点一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca8e8585523, createdName=ms4000001388192116, createdTime=Thu Oct 12 13:01:03 CST 2023, time=2023-10-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2164004, encodeId=f7b92164004c8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：生物信息学 经验分享：Publishing and rights Submission status Date Publishing and rights complete 07 Sep 2023 Submission is in publishing and rights 07 Sep 2023 Peer review Submission status Date Submission accepted 05 Sep 2023 Submission under peer review 28 Aug 2023 Submission passed technical check 28 Aug 2023 Amendment received 24 Aug 2023 Amendment received 23 Aug 2023 Revision received 13 Aug 2023 Submission under peer review 25 Feb 2023 Technical check Submission status Date Submission passed technical check 25 Feb 2023 Amendment received 23 Feb 2023 Submission is under technical check 17 Feb 2023 Submission received Submission status Date Submission received 17 Feb 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bad6163337, createdName=ms2000001312611838, createdTime=Fri Oct 20 20:54:30 CST 2023, time=2023-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161997, encodeId=95c2216199efb, content=2023.04.17提交 2023.04.21外审 2023.08.30修稿 2023.09.13修回 2023.10.02二修 2023.10.10接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Tue Oct 10 16:57:31 CST 2023, time=2023-10-10, status=1, ipAttribution=塔斯马尼亚), GetPortalCommentsPageByObjectIdResponse(id=2145375, encodeId=d05521453e583, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：有限元;骨科 经验分享：我去年投稿的时候还感觉这个杂志社处理稿件还挺快的，今年突然就慢性下来了，初审都拖了1个星期，给的拒稿理由也很泛泛，感觉变天了啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOV8qWmN9XB26YdMI8wKzQLQO3ZOb9aicDDU9GDKyrZdE822FcswP6WCek3goEKXSY49Or6iaiaEZ2A/132, createdBy=01755164162, createdName=接骨中郎匠, createdTime=Thu Jun 29 08:30:19 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省)]

2023-10-12 ms4000001388192116 来自江苏省

上个月显示邀请30位审稿人，昨天显示邀请79位审稿人？？？？？啥意思？哪位大神指点一下。

17 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2164221, encodeId=60be21642210e, content=偏重的研究方向：脊柱 经验分享：23.9.11投稿，23.9.25过格式审查，十月初邀请到编辑处理，具体哪一天忘记了，然后送审以后处理速度还是很快，三位审稿人接受邀请，23.10.20第一位审稿人意见反馈，继续等待，希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/STQuHjjJKMYl69lTpXIUI5u3woQuKskqLpsia8jC0M8lfDTTISjic4ekEeDKYQ6B3iaedCtqiaQicAn2lKENsicHAsIQ/132, createdBy=a36c2405777, createdName=ssssdsfwaefwa, createdTime=Sun Oct 22 17:24:52 CST 2023, time=2023-10-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2172622, encodeId=62bf21e262257, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;骨科 经验分享：年中旬投了篇单细胞的生信，补实验后顺利接受，推荐给同学，上个月投了篇孟德尔，秒拒，我师兄的生信投这里也拒了，建议数据挖掘类的文章慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bad6163337, createdName=ms2000001312611838, createdTime=Sun Dec 03 09:29:36 CST 2023, time=2023-12-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2166338, encodeId=8a0d216633800, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投稿到接收差不多两个月，生信+实验验证，返修补了一些实验 Submission is in publishing and rights 30 Oct 2023 Submission accepted 30 Oct 2023 Submission under peer review 13 Oct 2023 Submission passed technical check 13 Oct 2023 Amendment received 13 Oct 2023 Revision received 11 Oct 2023 Submission under peer review 14 Sep 2023 Technical check Submission status Date Submission passed technical check 14 Sep 2023 Amendment received 14 Sep 2023 Submission is under technical check 23 Aug 2023 Submission received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/7e6dda2a286d404d897e281e83f93dee/0c32f4acbf6d461481aa19e7dc94d95f.png, createdBy=b4952354890, createdName=Adamt, createdTime=Thu Nov 02 18:20:20 CST 2023, time=2023-11-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2157142, encodeId=887d215e1427e, content=这个杂志技术审查那么久啊，一个月了，还没审查结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d1c5490951, createdName=万里无云, createdTime=Mon Sep 11 15:12:17 CST 2023, time=2023-09-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2099480, encodeId=81922099480b4, content=偏重的研究方向：骨科;骨性关节炎 经验分享：Editors invited一般持续多长时间，10月21号开始Editors invited到现在已经将近20天了，还没有动静，要不要催催，求助😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1688361305, createdName=ms3000000919382660, createdTime=Wed Nov 09 21:16:05 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131567, encodeId=d1d6213156e62, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：骨科 经验分享：投稿历时7个月，第4个月的时候还在邀请审稿人，写邮件问了一下，说找不到审稿人，第二天看到同时邀请40个审稿人，头一次见这么大的阵仗，最终有一个审稿人接受了审稿。第6个月的时候审稿意见回来了，编辑给了小修意见，认真修改后提交文章，最终拒了。拒稿的理由也够奇葩，说样本量和随访时间的问题。如果是这样，那就早点拒啊，真的是崩溃了。 Submission rejected 03May2023 Submission under peer review 07Apr2023 Submission passed technical check 07Apr2023 Revision received 07Apr2023 Submission under peer review 02 Nov 2022 Submission passed technical check 02Nov2022 Amendment received 02Nov2022 Submission is under technical check 270ct 2022 Submission received 270ct 2022 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230717/d63097b66c1440faac5ec06c017e0793/06610422a28d4ec6ae0d7bf160d09e30.jpg, createdBy=b4db1647753, createdName=ala, createdTime=Thu May 11 11:40:21 CST 2023, time=2023-05-11, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2162346, encodeId=c4232162346f0, content=上个月显示邀请30位审稿人，昨天显示邀请79位审稿人？？？？？啥意思？哪位大神指点一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca8e8585523, createdName=ms4000001388192116, createdTime=Thu Oct 12 13:01:03 CST 2023, time=2023-10-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2164004, encodeId=f7b92164004c8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：生物信息学 经验分享：Publishing and rights Submission status Date Publishing and rights complete 07 Sep 2023 Submission is in publishing and rights 07 Sep 2023 Peer review Submission status Date Submission accepted 05 Sep 2023 Submission under peer review 28 Aug 2023 Submission passed technical check 28 Aug 2023 Amendment received 24 Aug 2023 Amendment received 23 Aug 2023 Revision received 13 Aug 2023 Submission under peer review 25 Feb 2023 Technical check Submission status Date Submission passed technical check 25 Feb 2023 Amendment received 23 Feb 2023 Submission is under technical check 17 Feb 2023 Submission received Submission status Date Submission received 17 Feb 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bad6163337, createdName=ms2000001312611838, createdTime=Fri Oct 20 20:54:30 CST 2023, time=2023-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161997, encodeId=95c2216199efb, content=2023.04.17提交 2023.04.21外审 2023.08.30修稿 2023.09.13修回 2023.10.02二修 2023.10.10接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Tue Oct 10 16:57:31 CST 2023, time=2023-10-10, status=1, ipAttribution=塔斯马尼亚), GetPortalCommentsPageByObjectIdResponse(id=2145375, encodeId=d05521453e583, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：有限元;骨科 经验分享：我去年投稿的时候还感觉这个杂志社处理稿件还挺快的，今年突然就慢性下来了，初审都拖了1个星期，给的拒稿理由也很泛泛，感觉变天了啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOV8qWmN9XB26YdMI8wKzQLQO3ZOb9aicDDU9GDKyrZdE822FcswP6WCek3goEKXSY49Or6iaiaEZ2A/132, createdBy=01755164162, createdName=接骨中郎匠, createdTime=Thu Jun 29 08:30:19 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省)]

2023-10-20 ms2000001312611838

审稿速度:3.0 | 投稿命中率:95.0
偏重的研究方向：生物信息学
经验分享：Publishing and rights
Submission status Date
Publishing and rights complete
07 Sep 2023
Submission is in publishing and rights
07 Sep 2023
Peer review
Submission status Date
Submission accepted
05 Sep 2023
Submission under peer review
28 Aug 2023
Submission passed technical check
28 Aug 2023
Amendment received
24 Aug 2023
Amendment received
23 Aug 2023
Revision received
13 Aug 2023
Submission under peer review
25 Feb 2023
Technical check
Submission status Date
Submission passed technical check
25 Feb 2023
Amendment received
23 Feb 2023
Submission is under technical check
17 Feb 2023
Submission received
Submission status Date
Submission received
17 Feb 2023

10 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2164221, encodeId=60be21642210e, content=偏重的研究方向：脊柱 经验分享：23.9.11投稿，23.9.25过格式审查，十月初邀请到编辑处理，具体哪一天忘记了，然后送审以后处理速度还是很快，三位审稿人接受邀请，23.10.20第一位审稿人意见反馈，继续等待，希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/STQuHjjJKMYl69lTpXIUI5u3woQuKskqLpsia8jC0M8lfDTTISjic4ekEeDKYQ6B3iaedCtqiaQicAn2lKENsicHAsIQ/132, createdBy=a36c2405777, createdName=ssssdsfwaefwa, createdTime=Sun Oct 22 17:24:52 CST 2023, time=2023-10-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2172622, encodeId=62bf21e262257, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;骨科 经验分享：年中旬投了篇单细胞的生信，补实验后顺利接受，推荐给同学，上个月投了篇孟德尔，秒拒，我师兄的生信投这里也拒了，建议数据挖掘类的文章慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bad6163337, createdName=ms2000001312611838, createdTime=Sun Dec 03 09:29:36 CST 2023, time=2023-12-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2166338, encodeId=8a0d216633800, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投稿到接收差不多两个月，生信+实验验证，返修补了一些实验 Submission is in publishing and rights 30 Oct 2023 Submission accepted 30 Oct 2023 Submission under peer review 13 Oct 2023 Submission passed technical check 13 Oct 2023 Amendment received 13 Oct 2023 Revision received 11 Oct 2023 Submission under peer review 14 Sep 2023 Technical check Submission status Date Submission passed technical check 14 Sep 2023 Amendment received 14 Sep 2023 Submission is under technical check 23 Aug 2023 Submission received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/7e6dda2a286d404d897e281e83f93dee/0c32f4acbf6d461481aa19e7dc94d95f.png, createdBy=b4952354890, createdName=Adamt, createdTime=Thu Nov 02 18:20:20 CST 2023, time=2023-11-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2157142, encodeId=887d215e1427e, content=这个杂志技术审查那么久啊，一个月了，还没审查结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d1c5490951, createdName=万里无云, createdTime=Mon Sep 11 15:12:17 CST 2023, time=2023-09-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2099480, encodeId=81922099480b4, content=偏重的研究方向：骨科;骨性关节炎 经验分享：Editors invited一般持续多长时间，10月21号开始Editors invited到现在已经将近20天了，还没有动静，要不要催催，求助😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1688361305, createdName=ms3000000919382660, createdTime=Wed Nov 09 21:16:05 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131567, encodeId=d1d6213156e62, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：骨科 经验分享：投稿历时7个月，第4个月的时候还在邀请审稿人，写邮件问了一下，说找不到审稿人，第二天看到同时邀请40个审稿人，头一次见这么大的阵仗，最终有一个审稿人接受了审稿。第6个月的时候审稿意见回来了，编辑给了小修意见，认真修改后提交文章，最终拒了。拒稿的理由也够奇葩，说样本量和随访时间的问题。如果是这样，那就早点拒啊，真的是崩溃了。 Submission rejected 03May2023 Submission under peer review 07Apr2023 Submission passed technical check 07Apr2023 Revision received 07Apr2023 Submission under peer review 02 Nov 2022 Submission passed technical check 02Nov2022 Amendment received 02Nov2022 Submission is under technical check 270ct 2022 Submission received 270ct 2022 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230717/d63097b66c1440faac5ec06c017e0793/06610422a28d4ec6ae0d7bf160d09e30.jpg, createdBy=b4db1647753, createdName=ala, createdTime=Thu May 11 11:40:21 CST 2023, time=2023-05-11, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2162346, encodeId=c4232162346f0, content=上个月显示邀请30位审稿人，昨天显示邀请79位审稿人？？？？？啥意思？哪位大神指点一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca8e8585523, createdName=ms4000001388192116, createdTime=Thu Oct 12 13:01:03 CST 2023, time=2023-10-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2164004, encodeId=f7b92164004c8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：生物信息学 经验分享：Publishing and rights Submission status Date Publishing and rights complete 07 Sep 2023 Submission is in publishing and rights 07 Sep 2023 Peer review Submission status Date Submission accepted 05 Sep 2023 Submission under peer review 28 Aug 2023 Submission passed technical check 28 Aug 2023 Amendment received 24 Aug 2023 Amendment received 23 Aug 2023 Revision received 13 Aug 2023 Submission under peer review 25 Feb 2023 Technical check Submission status Date Submission passed technical check 25 Feb 2023 Amendment received 23 Feb 2023 Submission is under technical check 17 Feb 2023 Submission received Submission status Date Submission received 17 Feb 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bad6163337, createdName=ms2000001312611838, createdTime=Fri Oct 20 20:54:30 CST 2023, time=2023-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161997, encodeId=95c2216199efb, content=2023.04.17提交 2023.04.21外审 2023.08.30修稿 2023.09.13修回 2023.10.02二修 2023.10.10接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Tue Oct 10 16:57:31 CST 2023, time=2023-10-10, status=1, ipAttribution=塔斯马尼亚), GetPortalCommentsPageByObjectIdResponse(id=2145375, encodeId=d05521453e583, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：有限元;骨科 经验分享：我去年投稿的时候还感觉这个杂志社处理稿件还挺快的，今年突然就慢性下来了，初审都拖了1个星期，给的拒稿理由也很泛泛，感觉变天了啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOV8qWmN9XB26YdMI8wKzQLQO3ZOb9aicDDU9GDKyrZdE822FcswP6WCek3goEKXSY49Or6iaiaEZ2A/132, createdBy=01755164162, createdName=接骨中郎匠, createdTime=Thu Jun 29 08:30:19 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省)]

2023-10-10 凶巴巴恰北北怪兽来自塔斯马尼亚

2023.04.17提交 2023.04.21外审 2023.08.30修稿 2023.09.13修回 2023.10.02二修 2023.10.10接收

18 0

[GetPortalCommentsPageByObjectIdResponse(id=2164221, encodeId=60be21642210e, content=偏重的研究方向：脊柱 经验分享：23.9.11投稿，23.9.25过格式审查，十月初邀请到编辑处理，具体哪一天忘记了，然后送审以后处理速度还是很快，三位审稿人接受邀请，23.10.20第一位审稿人意见反馈，继续等待，希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/STQuHjjJKMYl69lTpXIUI5u3woQuKskqLpsia8jC0M8lfDTTISjic4ekEeDKYQ6B3iaedCtqiaQicAn2lKENsicHAsIQ/132, createdBy=a36c2405777, createdName=ssssdsfwaefwa, createdTime=Sun Oct 22 17:24:52 CST 2023, time=2023-10-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2172622, encodeId=62bf21e262257, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;骨科 经验分享：年中旬投了篇单细胞的生信，补实验后顺利接受，推荐给同学，上个月投了篇孟德尔，秒拒，我师兄的生信投这里也拒了，建议数据挖掘类的文章慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bad6163337, createdName=ms2000001312611838, createdTime=Sun Dec 03 09:29:36 CST 2023, time=2023-12-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2166338, encodeId=8a0d216633800, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投稿到接收差不多两个月，生信+实验验证，返修补了一些实验 Submission is in publishing and rights 30 Oct 2023 Submission accepted 30 Oct 2023 Submission under peer review 13 Oct 2023 Submission passed technical check 13 Oct 2023 Amendment received 13 Oct 2023 Revision received 11 Oct 2023 Submission under peer review 14 Sep 2023 Technical check Submission status Date Submission passed technical check 14 Sep 2023 Amendment received 14 Sep 2023 Submission is under technical check 23 Aug 2023 Submission received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/7e6dda2a286d404d897e281e83f93dee/0c32f4acbf6d461481aa19e7dc94d95f.png, createdBy=b4952354890, createdName=Adamt, createdTime=Thu Nov 02 18:20:20 CST 2023, time=2023-11-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2157142, encodeId=887d215e1427e, content=这个杂志技术审查那么久啊，一个月了，还没审查结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d1c5490951, createdName=万里无云, createdTime=Mon Sep 11 15:12:17 CST 2023, time=2023-09-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2099480, encodeId=81922099480b4, content=偏重的研究方向：骨科;骨性关节炎 经验分享：Editors invited一般持续多长时间，10月21号开始Editors invited到现在已经将近20天了，还没有动静，要不要催催，求助😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1688361305, createdName=ms3000000919382660, createdTime=Wed Nov 09 21:16:05 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131567, encodeId=d1d6213156e62, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：骨科 经验分享：投稿历时7个月，第4个月的时候还在邀请审稿人，写邮件问了一下，说找不到审稿人，第二天看到同时邀请40个审稿人，头一次见这么大的阵仗，最终有一个审稿人接受了审稿。第6个月的时候审稿意见回来了，编辑给了小修意见，认真修改后提交文章，最终拒了。拒稿的理由也够奇葩，说样本量和随访时间的问题。如果是这样，那就早点拒啊，真的是崩溃了。 Submission rejected 03May2023 Submission under peer review 07Apr2023 Submission passed technical check 07Apr2023 Revision received 07Apr2023 Submission under peer review 02 Nov 2022 Submission passed technical check 02Nov2022 Amendment received 02Nov2022 Submission is under technical check 270ct 2022 Submission received 270ct 2022 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230717/d63097b66c1440faac5ec06c017e0793/06610422a28d4ec6ae0d7bf160d09e30.jpg, createdBy=b4db1647753, createdName=ala, createdTime=Thu May 11 11:40:21 CST 2023, time=2023-05-11, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2162346, encodeId=c4232162346f0, content=上个月显示邀请30位审稿人，昨天显示邀请79位审稿人？？？？？啥意思？哪位大神指点一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca8e8585523, createdName=ms4000001388192116, createdTime=Thu Oct 12 13:01:03 CST 2023, time=2023-10-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2164004, encodeId=f7b92164004c8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：生物信息学 经验分享：Publishing and rights Submission status Date Publishing and rights complete 07 Sep 2023 Submission is in publishing and rights 07 Sep 2023 Peer review Submission status Date Submission accepted 05 Sep 2023 Submission under peer review 28 Aug 2023 Submission passed technical check 28 Aug 2023 Amendment received 24 Aug 2023 Amendment received 23 Aug 2023 Revision received 13 Aug 2023 Submission under peer review 25 Feb 2023 Technical check Submission status Date Submission passed technical check 25 Feb 2023 Amendment received 23 Feb 2023 Submission is under technical check 17 Feb 2023 Submission received Submission status Date Submission received 17 Feb 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bad6163337, createdName=ms2000001312611838, createdTime=Fri Oct 20 20:54:30 CST 2023, time=2023-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161997, encodeId=95c2216199efb, content=2023.04.17提交 2023.04.21外审 2023.08.30修稿 2023.09.13修回 2023.10.02二修 2023.10.10接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Tue Oct 10 16:57:31 CST 2023, time=2023-10-10, status=1, ipAttribution=塔斯马尼亚), GetPortalCommentsPageByObjectIdResponse(id=2145375, encodeId=d05521453e583, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：有限元;骨科 经验分享：我去年投稿的时候还感觉这个杂志社处理稿件还挺快的，今年突然就慢性下来了，初审都拖了1个星期，给的拒稿理由也很泛泛，感觉变天了啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOV8qWmN9XB26YdMI8wKzQLQO3ZOb9aicDDU9GDKyrZdE822FcswP6WCek3goEKXSY49Or6iaiaEZ2A/132, createdBy=01755164162, createdName=接骨中郎匠, createdTime=Thu Jun 29 08:30:19 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省)]

2023-06-29 接骨中郎匠来自江苏省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：有限元;骨科
经验分享：我去年投稿的时候还感觉这个杂志社处理稿件还挺快的，今年突然就慢性下来了，初审都拖了1个星期，给的拒稿理由也很泛泛，感觉变天了啊！

80 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

平台业务解决方案

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务